- Home
- UCB vs MRUS Comparison
UCB vs MRUS Comparison
Compare UCB & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCB
- MRUS
- Stock Information
- Founded
- UCB 1950
- MRUS 2003
- Country
- UCB United States
- MRUS Netherlands
- Employees
- UCB 3071
- MRUS 229
- Industry
- UCB
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- UCB
- MRUS Health Care
- Exchange
- UCB NYSE
- MRUS Nasdaq
- Market Cap
- UCB 3.5B
- MRUS 3.5B
- IPO Year
- UCB 2002
- MRUS 2016
- Fundamental
- Price
- UCB $30.33
- MRUS $50.96
- Analyst Decision
- UCB
- MRUS Strong Buy
- Analyst Count
- UCB 0
- MRUS 10
- Target Price
- UCB N/A
- MRUS $82.20
- AVG Volume (30 Days)
- UCB 380.8K
- MRUS 417.6K
- Earning Date
- UCB 01-01-0001
- MRUS 10-31-2024
- Dividend Yield
- UCB 3.19%
- MRUS N/A
- EPS Growth
- UCB N/A
- MRUS N/A
- EPS
- UCB 1.54
- MRUS N/A
- Revenue
- UCB $828,860,000.00
- MRUS $35,193,000.00
- Revenue This Year
- UCB N/A
- MRUS N/A
- Revenue Next Year
- UCB N/A
- MRUS $70.55
- P/E Ratio
- UCB $18.99
- MRUS N/A
- Revenue Growth
- UCB N/A
- MRUS N/A
- 52 Week Low
- UCB $21.63
- MRUS $19.81
- 52 Week High
- UCB $31.96
- MRUS $61.61
- Technical
- Relative Strength Index (RSI)
- UCB N/A
- MRUS 39.97
- Support Level
- UCB N/A
- MRUS $49.08
- Resistance Level
- UCB N/A
- MRUS $51.23
- Average True Range (ATR)
- UCB 0.00
- MRUS 1.71
- MACD
- UCB 0.00
- MRUS -0.04
- Stochastic Oscillator
- UCB 0.00
- MRUS 26.64
About UCB UNITED COMMUNITY BANKS(GEORGIA)
United Community Banks Inc is a bank holding company that operates through its wholly-owned subsidiary, Union Community Bank. The bank has scores of offices throughout portions of Georgia, Tennessee, and the Carolinas. It has traditionally grown through the organic growth of existing offices and de novo locations, complemented by selective acquisitions. United conducts substantially all of its operations through a community-focused operating model of separate community banks. The community banks offer a full range of retail and corporate banking services, including checking, savings, and time deposit accounts, as well as secured and unsecured loans, wire transfers, brokerage services, and other financial services. The bank's loan portfolio is well-diversified but predominantly commercial.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.